Pseudo acute kidney injury in patients receiving CDK4/6 inhibitors
CDK4/6 inhibitors (CDK4/6i) improve progression-free survival in patients with advanced oestrogen-receptor-positive breast cancer. However, all CDK…
Category: Targeted therapies